bg image

Rx HOME – Static Banner

PROVIDE A UNIQUE PROFESSIONAL SERVICE

By offering myDNA in your pharmacy, you can now provide a more personalised service to your customers.

Contact us

DOCTOR – Pharmacogenomic

Hear from our Associate Professor Les Sheffield

DOCTOR – About the myDNA test

About our test

The myDNA Medication test is a pharmacogenomic test where DNA analysis identifies variations in a number of genes that influence medication response.

A comprehensive report is written by the myDNA clinical team and includes an interpretation of the patient’s genetic results, any prescribing considerations for current medications, as well as information on other medications covered by the myDNA test so that this can be referred to for the future.

Currently, myDNA Medication reports particularly concentrate on the genes encoding metabolising enzymes (i.e. CYP450 enzymes) which are found mainly in the liver as well as the gut wall. These genetic variations predict the level of enzyme activity which in turn results in increased or decreased plasma concentrations and drug exposure.

For many medications increased plasma concentrations, due to reduced enzyme activity, can lead to adverse effects. Reduced plasma concentrations, due to increased enzyme activity, can lead to poor therapeutic response.

Enzyme function can also be affected by factors other than genotype, including age, the effect of co-administered drugs (i.e. drug-drug interactions), and the presence of liver disease. These should be taken into account when considering the myDNA Medication Reports.

Reports must be delivered by a suitable healthcare professional. myDNA provides training for medical staff to assist in the understanding of these reports. If you would like to know more about this training, please email us: clinical@mydna.life.

Our myDNA healthcare professional clinical support line is also available on 1300 436 373 9am-5pm (AEST) business days to provide information on the test, including details of which medications are currently covered and provide clinical guidance on test results.

References Clinical FAQs Medications covered

DOCTOR – Who is it Recommended For

The patients likely to benefit from myDNA testing include those who are:

The patients likely to benefit from myDNA testing include those who are:

  • Experiencing side effects to specific medications
  • Not responding to specific medications
  • Requiring doses of specific medications outside the recommended range
  • Planning to start on a new medication covered by the myDNA test
  • Taking multiple medications initiated by different prescribers

Each person who takes a myDNA test will receive a highly customized medication report and ongoing access to their Explore myDNA – a secure online portal that provides information relevant to the person’s genetic profile.

Rx HOME – Want to Learn More

WANT TO LEARN MORE?

Call us at 1 844 472 7896

Become Accredited

Rx HOME – Testing in Pharmacies

Pharmacogenomic testing in pharmacies

myDNA was the first to offer pharmacogenomic testing in Australian pharmacies in 2015. Today it is available in more than 1,000 pharmacies nationwide.

Participating pharmacies are at the forefront of personalised medicine and are able to provide an enhanced service to their customers.

Rx HOME – Treatment success

The myDNA test allows pharmacists to:

bg image

Rx HOME – Benefits

PROVIDE TREATMENT OUTCOMES

BUILD STRONGER RELATIONSHIPS

OFFER A PERSONALISED
HEALTH SERVICE

 

PROVIDE A POINT OF DIFFERENCE

EXPAND THEIR
HEALTH SERVICES

ENCOURAGE PROFESSIONAL DEVELOPMENT

Rx HOME – Offering myDNA

Offering myDNA in your pharmacy

Offering the myDNA program in your pharmacy is simple. Each pharmacy’s program manager nominates staff members who undertake comprehensive myDNA training.

We have helpful support staff and a clinical team if you ever require any assistance along the way.

MEDS – Stories

Stories

Rachel shares her story

Joy shares her story

Rx HOME – Want to Learn More

WANT TO LEARN MORE?

Call us at 1 844 472 7896

Become Accredited